Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first-line antihypertensive therapy.

导出 OA

翻译打印收藏纠错

第一作者： Revathy,Carnagarin

第一单位： Faculty of Medicine, Dentistry & Health Sciences, School of Medicine - Royal Perth Hospital Unit, Dobney Hypertension Centre, Royal Perth Hospital Research Foundation, The University of Western Australia, Perth, WA, Australia.

作者： Revathy,Carnagarin ^[1] ; Janis M,Nolde ^[1] ; Natalie C,Ward ^[1] ; Leslie Marisol,Lugo-Gavidia ^[1] ; Justine,Chan ^[1] ; Sandi,Robinson ^[1] ; Ancy,Jose ^[1] ; Anu,Joyson ^[1] ; Omar,Azzam ^[1] ; Márcio,Galindo Kiuchi ^[1] ; Bibombe P,Mwipatayi ^[2] ; Markus P,Schlaich ^[3]

作者单位： Faculty of Medicine, Dentistry & Health Sciences, School of Medicine - Royal Perth Hospital Unit, Dobney Hypertension Centre, Royal Perth Hospital Research Foundation, The University of Western Australia, Perth, WA, Australia. ^[1] Department of Vascular Surgery, Royal Perth Hospital, Perth, WA, Australia. ^[2] Faculty of Medicine, School of Surgery, Dentistry and Health Sciences, University of Western Australia, Perth, WA, Australia. ^[3] Departments of Cardiology and Nephrology, Royal Perth Hospital, Perth, WA, Australia. ^[4] Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Vic., Australia. ^[5]

关键词 blood pressure homocysteine hypertension hypertension mediated organ damage pulse wave velocity